ImClone Systems Inc. (IMCL)

IMCL is defunct.

IMCL Related Articles more »

Changing the Perception of the Biotech One-Trick Pony

Jason Chew • Tue, Dec 7, 2010 • 9 Comments
Dividend Aristocrats: 3 to Watch

Avi Morris • Tue, Oct 20, 2009 • 12 Comments
VC Financings Boost Interest in Biotech

The Burrill Report • Fri, Jul 24, 2009 • Comment!
A Look at D.E. Shaw's Q408 Holdings: Just for Fun

Market Folly • Wed, Apr 22, 2009 • 1 Comment
Moore Capital Investments: Theme Is Economic Recovery

Market Folly • Wed, Mar 18, 2009 • 4 Comments
Carl Icahn's Top Three Stock Ideas

The Manual of Ideas • Thu, Mar 5, 2009 • 2 Comments
A Comparison of M&A Activity During Bull and Bear markets

Dr. Kris • Fri, Jan 30, 2009 • 2 Comments
Hedge Fund Portfolio Tracking: D.E. Shaw & Co (David E. Shaw), Q3 2008

Market Folly • Fri, Jan 16, 2009 • 1 Comment
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008

Market Folly • Thu, Jan 15, 2009 • Comment!
2009: Positive Outlook for Biotech

Michael Becker • Thu, Jan 8, 2009 • 1 Comment

IMCL Latest Transcript more »

ImClone Systems, Inc. Q1 2008 Earnings Call Transcript

Tue, Apr 29, 2008
Popular searches: growth, crystal, imclone, bristol, data, erbitux, hollister.

Earlier IMCL transcripts

IMCL Cramer more »

Imminent Rate Cut? - Cramer's Stop Trading! (10/3/08)

Fri, Oct 3, 2008
Buy AMD Here - Cramer's Lightning Round (8/13/08)

Thu, Aug 14, 2008
Good Earnings, Good Buy - Cramer's Mad Money (8/11/08)

Tue, Aug 12, 2008

IMCL Instablog posts more »

Activist Hedge Funds are increasingly pushing former CEOs onto Boards

Fri, Apr 16, 2010 • Todd Walker • Comment!

Company Description

We are a biopharmaceutical company whose mission is to advance oncology care by developing and commercializing a portfolio of targeted treatments designed to address the medical needs of patients with cancer. We focus on what we believe are two promising strategies for treating cancer: growth... More

Country: United States